GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Center Laboratories Inc (ROCO:4123) » Definitions » Cyclically Adjusted Revenue per Share

Center Laboratories (ROCO:4123) Cyclically Adjusted Revenue per Share : NT$14.93 (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Center Laboratories Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Center Laboratories's adjusted revenue per share for the three months ended in Mar. 2024 was NT$0.526. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$14.93 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Center Laboratories's average Cyclically Adjusted Revenue Growth Rate was 3.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Center Laboratories was 4.70% per year. The lowest was -0.20% per year. And the median was 3.60% per year.

As of today (2024-06-09), Center Laboratories's current stock price is NT$48.40. Center Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was NT$14.93. Center Laboratories's Cyclically Adjusted PS Ratio of today is 3.24.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Center Laboratories was 4.97. The lowest was 1.89. And the median was 3.36.


Center Laboratories Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Center Laboratories's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Center Laboratories Cyclically Adjusted Revenue per Share Chart

Center Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.78 12.79 13.51 14.23 14.67

Center Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.46 14.61 14.73 14.67 14.93

Competitive Comparison of Center Laboratories's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Center Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Center Laboratories's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Center Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Center Laboratories's Cyclically Adjusted PS Ratio falls into.



Center Laboratories Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Center Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.526/131.7762*131.7762
=0.526

Current CPI (Mar. 2024) = 131.7762.

Center Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.513 100.560 0.672
201409 0.543 100.428 0.712
201412 0.532 99.070 0.708
201503 0.511 99.621 0.676
201506 0.585 100.684 0.766
201509 4.267 100.392 5.601
201512 5.691 99.792 7.515
201603 6.086 100.470 7.982
201606 6.903 101.688 8.946
201609 6.267 101.861 8.108
201612 8.128 101.863 10.515
201703 6.885 102.862 8.820
201706 7.626 103.349 9.724
201709 8.925 104.136 11.294
201712 10.686 104.011 13.539
201803 9.417 105.290 11.786
201806 12.716 106.317 15.761
201809 9.719 106.507 12.025
201812 4.016 105.998 4.993
201903 0.620 107.251 0.762
201906 0.614 108.070 0.749
201909 0.585 108.329 0.712
201912 0.636 108.420 0.773
202003 0.491 108.902 0.594
202006 0.175 108.767 0.212
202009 0.206 109.815 0.247
202012 0.258 109.897 0.309
202103 0.238 111.754 0.281
202106 0.201 114.631 0.231
202109 0.138 115.734 0.157
202112 0.181 117.630 0.203
202203 0.227 121.301 0.247
202206 0.320 125.017 0.337
202209 0.265 125.227 0.279
202212 0.365 125.222 0.384
202303 0.488 127.348 0.505
202306 0.477 128.729 0.488
202309 0.519 129.860 0.527
202312 0.587 129.419 0.598
202403 0.526 131.776 0.526

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Center Laboratories  (ROCO:4123) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Center Laboratories's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=48.40/14.93
=3.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Center Laboratories was 4.97. The lowest was 1.89. And the median was 3.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Center Laboratories Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Center Laboratories's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Center Laboratories (ROCO:4123) Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 3-2, Park Street, 7th floor, Nangang District, Taipei, TWN
Center Laboratories Inc is active in the healthcare sector. The company provides solutions to special medication needs of infants, young children, the elderly, patients with dysphagia and special population. In addition to the diversification of new formulations of oral solution, Center Laboratories is dedicated to new drug development of CNS and pain treatment.

Center Laboratories (ROCO:4123) Headlines

No Headlines